Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

A social media platform has removed several posts promoting unapproved injections of experimental drugs known as "Reta Pens".

Foundation Medicine, Inc ., a global, patient-focused precision medicine company , today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® ...

In this cohort study of patients with early breast cancer, prediagnostic statin use was not associated with higher survival; however, postdiagnostic statin use was associated with lower all-cause and ...

Advances in genomic testing are helping doctors identify which tumours truly need chemotherapy — and which patients may do ...

'I felt completely robbed of my pregnancy and newborn period and maternity leave.' ...

Roche (RHHBF) stock is in focus as the FDA grants priority review for breast cancer therapy giredestrant with a target action ...

In this analysis, researchers examined the efficacy of adjuvant giredestrant in early breast cancer patients by menopausal ...

Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced that the U.S. Food and Drug Administration ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the United States (U.S.) Food and Drug Administration (FDA) has accepted the company’s New Drug Application ...

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...